Position in ATAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$110,855
New position
Shares Held
31,315
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cresset Asset Management, LLC holds $83,905,083 across 42 Biotechnology names. ATAI ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
739,191 | $38,630,121 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
259,397 | $16,764,828 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,860 | $3,509,804 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13,633 | $2,577,318 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
86,063 | $2,130,919 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
72,435 | $2,028,904 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,537 | $1,960,187 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
11,860 | $1,478,349 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,855 | 31,315 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||